Top Management Tactics & Long-Term Strategies for Senior Biopharma Executives Steering through COVID-19 and Beyond

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consulting; Medical Device; Health Care; Technology; Clinical Research; Laboratories; Science


Companies Profiled:
Almirall; Apellis Pharmaceuticals; Astellas; Biofrontera; Biogen; Boehringer Ingelheim; Ferozsons Laboratories Limited; Halloran Consulting Group; Helsinn; Joerns Healthcare; Kala Pharmaceuticals; Inc.; Kaleo; Medacta USA; MEDiSTRAVA; Mint Pharmaceuticals Inc.; Mirador Analytics Ltd.; Monebo Technologies; Nevakar; Novartis; Nuvisan; Pfizer; Purdue Pharma; Samumed; Sandoz; Sanofi; Santen; SomaGenics Inc; Syneos Health; Takeda Pharmaceuticals; The Medical Affairs Company; Thermo Fisher Scientific; UCB Pharma; Vertex Pharmaceuticals; XG Sciences; Inc

Study Snapshot

Best Practices, LLC engaged 40 executives from 34 life science companies in this research through a benchmarking survey. Nearly 60% of surveyed participants served at the C-suite, President or Vice President level.

Key topics covered in this report include:

• Top management objectives & effective day-to-day practices
• Key financial & operational decisions being made
• Key lessons & long-term opportunities
• Management perspectives of Senior Executives vs. Function Heads

• Top short-term priorities:

• Health: Ensuring employee and patient health are top short-term goals
• Ops & finance: Operations and financial considerations are 3rd and 4th among 12 surveyed senior-executive objectives
• Digital transformation comes next, superseding immediate business results, external engagement strategy, innovation, alliances and regulatory

Sr. No.	Topic	Slide No.
I.	Overview	p. 3
	Universe of Learning	p. 4
	Key Takeaways to Guide Senior Execs During & After COVID-19	p. 5
II.	Top Management Objectives & Effective Day-to-Day Practices	p. 7
III.	Key Financial & Operational Decisions Being Made	p. 15
IV.	Long-term Opportunities	p. 20
V.	Management Perspectives of Senior Executives vs Function Heads	p. 28
VI.	APPENDIX A: Profile of Study Participants	p. 37
VII.	APPENDIX B: Additional Benchmark Data	p. 40
VIII.	About Best Practices, LLC	p. 48

• Ranking of each of the listed objectives for senior management on a day-to-day basis during this pandemic
• Key short-term management objectives within benchmark organizations during this pandemic
• Top management tactics and actions for achieving key management and organizational objectives
• Executive voices from the field about COVID-19 task forces
• Beneficial tactics in achieving key management and organizational objectives
• Executive voices from the field on the action taken by organizations to provide effective leadership during the COVID-19 pandemic
• Voices from the field around driving a strong communication loop

• Changes in investment patterns in response to the COVID-19 pandemic
• New budget trends in response to COVID-19 pandemic
• Ranking of effective cost cutting measures
• Effectiveness of listed measures in reducing costs, while still maintaining strong performance and morale during the pandemic

• Ranking of key bellwethers
• Importance of each of the listed indicators in driving critical organizational decisions
• Interview narrative around weekly COVID-19 reports from key teams
• Timeline to address new challenges & opportunities
• Point at which benchmark organizations will begin to take action to meet new challenges and opportunities arising from the pandemic
• Most important area to strengthen to capitalize on new long-term opportunities
• Top advices from biopharma peers who are also managing through the COVID-19 pandemic

• Job titles of participants from Senior Executive segment and Function Head segment
• Absolutely critical short-term management objectives for Senior Executives and Function Heads
• Beneficial management tactics and actions for achieving key management and organizational objectives - Senior Executives vs. Function Heads
• Key bellwethers in driving critical organizational decisions for Senior Executives and Function Heads
• New budget investment policy - Senior Executives vs. Function Heads
• Effective cost cutting measures - Senior Executives vs. Function Heads
• Long-term objectives for Senior Executives and Function Heads
• Addressing operational challenges and opportunities - Senior Executives vs. Function Heads